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Young shoots of Rubus species have been used for healing of wounds, infected insect bites and pimples in folk medicine for ages.
In order to evaluate the wound healing activity of Rubus sanctus,f o u rd i ﬀerent extracts were prepared from the whole aerial parts
of the plant by using n-hexane, chloroform, ethyl acetate and methanol, respectively. Incision wound healing model by using
tensiometer on rats and excision model on mice were employed to assess the activity. Remarkable wound healing activity was
observed with the ointment formulation of the methanol extract at 1% concentration on the mentioned models. The results of
histopathologicalexaminationalsosupported theoutcomeofboth incisionand excision woundmodels.The woundhealingeﬀect
was comparatively evaluated with a reference ointment Madecassol.The experimental data conﬁrmed the ethnobotanical usage of
R. sanctus.
1.Introduction
Rubus species (Rubus sp.) (Rosaceae) have been traditionally
usedfortherapeuticpurposes. Forinstance, extractsofleaves
and roots of this genus have been used for the treatment
of diabetes mellitus, rheumatism, sore throat, hemorrhoid,
diarrhea and similar enteric disorders [1–5]. Particularly,
decoction prepared from the roots of Rubus sanctus Schreber
is used as herbal tea to alleviate pain and to heal rheumatism
[6]. Moreover, dried and crushed young shoots of Rubus sp.
have been applied onto wounds, infected insect bites and
pimples [7].
Several biological activity tests have been carried out so
far under laboratory conditions on Rubus species, which
focus on antimicrobial [8, 9], radical scavenging [10],
anticonvulsant muscle relaxant [11] and antinﬂammatory
and antinociceptive activities [12, 13]. According to phy-
tochemical analysis the plant extract characterized by their
capability of synthesizing and accumulating ellagitannins
containing a sanguisorboyl group [14]. They have also been
found to metabolise several phenolic carboxylic acids, such
as ellagic acid, and phenyl propanoids, particularly caﬀeic
acid [15]. In a previous study, the aerial parts of R. sanctus,
R. hirtus Walds. et Kit and their hybrid were evaluated for
their anti-inﬂammatory activity using carrageenan-induced
hind paw edema on mice and polar fractions, n-butanol and
remaining aqueous fractions obtained by solvent extraction,
were shown to possess signiﬁcant activity [12]. In a diﬀerent
study on Rubus sp., ethanolic extracts of R. sanctus (root
and aerial part) and R. hirtus (aerial parts) showed potent
antinociceptive activity, while that of aqueous extracts had
weak [13].However,itshouldbenotedthatinthesamestudy
both plants’ extracts had tendency to induce gastric dam-
age. Ongoing studies revealed the novel anti-inﬂammatory
triterpenoids, tormentic acid and euscaphic acid, which were
isolated from the fresh leaves of R. sieboldii Blume [16].
Furthermore, phytochemical studies exposed chemical
content of the aerial parts of some Rubus sp., which con-tain
ﬂavonoids (quercetin, kaempferol, caﬀeic acid and chloro-
genic acid), phenolic acids, tannins, amino acids, sugars, pe-
ctins, carboxylic acids, anthocyanins, catechins, vitamin C
and saturated or unsaturated fatty acids [17–20].
A surveyof the published literatures revealedthat wound
healing property of R. sanctus has not been subjected to in
vivoinvestigation by using incision and excision models.
The goals of the pharmacology of wound healing are
to evaluate the inﬂuence of various measures in wound
management programs on healing and to screen drugs that2 Evidence-Based Complementary and Alternative Medicine
encourage healing. Several candidates have so far been used
and were declared to aﬀect healing in various ways. Never-
theless, thorough research in wound healing has not yielded,
economicandeﬃcientpro-healing agentthatcouldpreclude
the long hospitalization of patients following surgery and
wound imposition. The present investigations were planned
to study the wound healing activity of R. sanctus Shreber.
We undertook the present activity screening study in order
to evaluate traditional use of this plant in terms of scientiﬁc
point.Then-hexane, chloroform,ethylacetateand methanol
extracts prepared from the aerial parts of R. sanctus were
testedinratsandmiceforwound healingactivityvia incision
by using tensiometer and excision wound models.
2.Methods
2.1. Plant Material. Rubus sanctus Schreber aerial parts were
collected from Kıbrısk¨ oy village, Ankara, Turkey during
June to July, 2007. The plant was authenticated by Serdar
Arslan from Gazi University, Department of Biology, Faculty
of Science and Art, Ankara, and a voucher specimen
(GUE 2604) was deposited in the Herbarium of Faculty of
Pharmacy, Gazi University, Ankara, Turkey.
2.2. Preparation of Plant Extracts. The plant material was
shade dried and powdered. Each 50g of powdered aerial
parts was submitted to successive solvent extractions sepa-
ratelywithn-hexane, chloroform,ethylacetateandmethanol
at room temperature for 24h (3 × 500ml each solvent).
Afterﬁltration,theextractswereevaporatedbyusingarotary
evaporator (Buchi, Switzerland) at 40◦Ct od r y n e s sin vacuo.
Yields of each extracts were 8.3% for n-hexane, 17.6% for
chloroform, 9.2% for ethyl acetate and 47.5% for methanol.
2.3. Wound Healing Activity Tests
2.3.1. Animals. Male, Sprague-Dawley rats (160–180 g) and
Swiss albino mice (20–25 g) were purchased from the animal
breeding laboratories of Reﬁk Saydam Central Institute of
Health (Ankara, Turkey).
The animals were left for 3 days at room conditions for
acclimatization. They were maintained on standard pellet
diet and water ad libitum throughout the experiment. A
minimum of six animals were used in each group, otherwise
described in procedure. The study was permitted by the
Institutional Animal Ethics Committee (Gazi University
Ethical Council Project Number: G.U.ET-08.037) and was
performed according to the international rules considering
the animal experiments and biodiversity right.
2.3.2. Preparation of Test Samples for Bioassay. Incision and
excision wound models were used to evaluate the wound
healing activity. For the in vivo wound models, test samples
were prepared in an ointment base (vehicle) consisting of
glycol stearat, 1,2 propylene glycol, liquid paraﬃn(3:6:1)
in 1% concentration. Each test ointment (0.5g) was applied
topically on the wounded site immediately after wound was
created by a surgical blade.
The vehicle group of animals was treated with the oint-
ment base only, whereas the reference drug group of animals
were treated with 0.5g of Madecassol (Bayer, 00001199).
Madecassol contains 1% extract of Centalla asiatica.
2.3.3. Linear Incision Wound Model. All the animals were
anaesthetized with 0.15cm3 Ketalar and the back hair of the
ratswere shavedbyusingashaving machine. Five-centimeter
long, two linear-paravertebral incisions were made with a
sterile surgical blade through the full thickness of the skin
at the distance of 1.5cm from the midline of each side
of the vertebral column [21]. The wounds were closed
with three surgical interrupted sutures of 1 cm apart. All
the sutures used in the experiments were non-absorbable
braided non-capillary and siliconized. The animals were
randomly distributed into four major groups; the extracts,
the reference drug the vehicle and the negative control.
Six rats (160–180g) were kept in each group. The negative
control group of animals was not treated with any material,
whereas the extracts, the reference drug (Madecassol) and
the vehicle were applied topically once in a day throughout
9 days. All the sutures were removed on the 9th post wound
day. On Day 10 all the animals were killed under anesthesia.
One linear-paravertebral incised skin was measured using
tensiometer (Zwick/Roell Z0.5, Germany) for its tensile
strength in Newtons, the other incised skin was sent for
histopathological examination [22, 23].
2.3.4. Excision Wound Model. This model was employed
to have information about wound contraction and wound
closure time on extract applied mice compared to controls.
Initially, all the animals were anaesthetized by 0.01cm3 Keta-
lar. The back hairs of the animals were depilated by shaving.
A circular wound was created on the dorsal interscapular
region of each animal by excising the skin with a 5mm
biopsy punch; wounds were left open [24]. The extracts,
the reference drug (Madecassol Bayer) and the vehicle were
applied topically once a day on to each group (six mice) of
animals, which were randomly distributed, till the wound
was completely healed. The progressive changes in wound
area were monitored by a camera (Fuji, S20 Pro, Japan)
every otherday. Later on, wound area was evaluatedby using
AutoCAD program. Wound contraction was calculated as
percentage of the reduction in wounded area. A specimen
sample of tissue was isolated from the healed skin of each
group of mice for the histopathological examination [25].
2.4. Histopathology. The cross-sectional full-thickness skin
specimens from each group were collected at the end of the
experiment to evaluate for the histopathological alterations.
Samples were ﬁxed in 10% buﬀered formalin, processed and
blocked with paraﬃn and then sectioned into 5μma n d
stained with hematoxylin & eosin (HE), Van Gieson’s (VG)
and toluidine blue (TB) stains [26]. Sections were analyzed
and scored as mild (+), moderate (++) and severe (+++) for
epidermal or dermal re-modeling. Re-epithelization or ulcus
in epidermis; ﬁbroblast proliferation, mononuclear and/or
polymorphonuclear cells, neovascularization and collagenEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Eﬀects of the extracts from R. sanctus on excision wound
model.
depositions in dermis were analyzed to scor the epidermal
or dermal re-modeling. Van Gieson’s stained sections were
checked for collagen deposition and toluidine blue stained
sections checked for metachromatic staining of mast cells. At
the end of the examination, all the wound healing processes
w e r ec o m b i n e da n ds t a g e df o rw o u n dh e a l i n gp h a s e sa s
inﬂammation, proliferation and re-modeling in all groups.
2.5. Statistical Analysis of the Data. The data on percentage
wound healing was statistically analyzed using one-way
analysis of variance (ANOVA). The values of P ≤ .001 were
consideredstatistically signiﬁcant. Histopathologicdatawere
consideredto benonparametric; therefore, no statistical tests
were performed.
3.Results
In this study, an investigation on the in vivo wound healing
activity of a medicinal plant, R. sanctus was carried out to
verify the claimed traditional uses of the plant. To assess
the wound healing activity of the aerial parts, extracts were
prepared with diﬀerentsolvents; n-hexane, chloroform, ethyl
acetate and methanol, respectively, from the aerial parts ofR.
sanctus. Incision by using tensiometer and excision wound
models were employed for this activity assessment
3.1. Excision Wound Model. The measurements of the pro-
gression of wound healing induced by the extracts, reference
drug, negative and vehicle groups are shown in Figure 1.I n
this excision wound model, the methanolic extract treated
groups of animals showed 56.5% contraction on the wounds
at Day 6. The same extract demonstrated 80.6% contraction
on the day 12, which was close to contraction value of
the reference drug Madecassol (100%). However, the other
extracts presented no signiﬁcant results.
3.2. Incision Wound Model. The results of the measurements
of tensile strength (in Newtons) are shown in Figure 2.
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Figure 2: Eﬀects of the extracts from R. sanctus on linear incision
wound model. N: Newton.
Tensile strength of the animals treated with the methanolic
extract demonstrated the highest value (38.9%) at day 10.
Topical application of the methanolic extract on the incision
wound model demonstrated a remarkable improvement in
wound tensile strength compared to other groups.
3.3. Histopathological Examination. Following histopatho-
logical examination, evaluated, scored and staged results
were combined, summarized and presented in Table 1.f o r
demonstrating of wound healing process, representative
ﬁgures (Figure 3), which stained with HE, VG and TB, were
also added.
Phases in wound healing processes (inﬂammation, pro-
liferation and remodeling) were observed and recorded
successfully within the experimental groups (Table 1). The
vehicle and the negative control groups demonstrated
delayed wound healing processes compared to the other
groups. In comparison with the vehicle and negative control
groups, faster re-modeling were noticed in extracts treated
groups. The best re-modeling, particularly, re-epithelization
were detected with the methanol extract group. On the other
hand, faster keratinizationcharacterized with minor intraep-
ithelial corniﬁcation was seen in n-hexane, chloroform and
ethyl acetate extract groups. Weak foreign body reaction,
superﬂuous process in wound healing, characterized with
a few foreign body giant cells, which generally localized in
peripheral sides of some hair follicles were detected in all
groups except for the reference drug Madecassol group.
4.Discussion
Wound healing process begins with the restoration of a
damaged tissue as closely as possible to its natural state and
wound contraction is the course of shrinkage in wounded
area. The healing primarily depends on the repairing ability
of the tissue in addition to type and degree of damage and
general health status of the tissue. The granulation tissue
of the wound is primarily composed of edema, ﬁbroblast,
collagen and new blood vessels. The mesenchymal cells
of the wound area adjust themselves into ﬁbroblast then
begin migrating into the wound gap together with the ﬁbrin4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Histopathological view of wound healing and epidermal/dermal re-modeling in the vehicle, negative control, R. sanctus extracts
andMadecassoladministered animals.Skinsections showthehematoxylin & eosin(HE) stainedepidermis anddermisin (a)andthe dermis
stained with Van Gieson’s (VG) and toluidine blue (TB) in (b) and (c) respectively. The original magniﬁcation was 40× and the scale bars
represent 25μm for ﬁgures in (a), and the original magniﬁcation was 400× and the scale bars represent 100μm for both (b) and (c). Data
are representative of six animal per group. (i) Vehicle group, 10 days old wound tissue treated with only vehicle, (ii) negative c ontrol group
(untreated), 10 days old wound tissue (iii) n-hexane extract group, 10 days old wound tissue treated with n-hexane extract, (iv) chloroform
extract group, 10 days old wound tissue treated with chloroform extract, (v) ethyl acetate extract group, 10 days old wound tissue treated
with ethyl acetate extract, (vi) methanol extract group, 10 days old wound tissue treated with methanol extract and (vi) Madecassol group,
10 day old wound tissue treated with Madecassol.Evidence-Based Complementary and Alternative Medicine 5
Table 1: Wound healing processes and healing phases of the vehicle, negative control, R. sanctus extracts and Madecassol administered
animalsa.
Groups Wound healing processes Healing phases
S U RE FP CD MNC PMN NV MC I P R
Vehicle +/+++ ++ −/+ ++ ++ + + +/++ + +++ ++ −
Negative control −/++ + −/++ +/++ +/++ −/+ + +/++ + +++ ++ −/+
Hexane extract + − ++ +/++ ++ −/+ − +++ + / + + + +
Chloroform extract + − ++ +/++ ++ + − +++ + / + + + +
Ethyl acetate extract + − ++ ++ ++ + − + +++ + +/++ ++
Methanol extract + − +++ + ++ −/+ −− /+ + −/+ −/+ +++
Madecassol +/++ − ++ ++ ++ −− ++ +/++ +/++ ++ +
S: Scab; U: Ulcus; RE: re-epithelization; FP: ﬁbroblast proliferation; CD: collagen depositions; MNC: mononuclear cells; PMN: polymorphonuclear cells; NV:
neovascularization; MC: Mast cells; I: inﬂammation phase; P: proliferation phase; R: re-modeling phase.
aHE, VG and TB stained sections were scored as mild (+), moderate (++) and severe (+++) for epidermal and/or dermal re-modeling.
strands. The collagen is the main constituentof extra cellular
tissue, which is responsible for support and strength. Free
hydroxyproline and its peptides are released with collapse
of collagen. Thus, measurement of the hydroxyproline could
be used as an indicator for collagen turnover. Furthermore,
increase in dry tissue also indicates the presence of elevated
proteincontent.The phytochemicalanalysis ofaerial partsof
R. sanctus revealed the presence of ﬂavonoids and phenolic
acid derivatives [14–16, 19]. Phenolic compounds, which
include tannins and ﬂavonoids, serve as ﬂoral pigments,
structural components, feeding attractants and deterrents,
of plants [27, 28]. Flavonoids have therapeutic uses due to
theiranti-inﬂammatory, anti-fungal, antioxidant andwound
healing properties [29–32]. Moreover, ﬂavonoids and their
derivatives are known to decrease lipid peroxidation by
improving vascularity and by preventing or slowing down
the progress of cell necrosis. Hence, any drug that inhibits
lipid peroxidation is supposed to increase the viability of
collagen ﬁbrils by increasing the circulation and the strength
of collagen ﬁbres, by encouraging the DNA synthesis and
preventing the cell damage [33, 34]. Flavonoids [35]a r e
also known to endorse the wound-healing process primar-
ily due to their antimicrobial and astringent properties,
which appears to be responsible for wound contraction
and elevated rate of epithelization. Corresponding types
of wound-healing eﬀect were reported on medicinal plants
[36, 37]. Therefore, wound-healing potential of R. sanctus
may be attributed to the phytoconstituents present in the
aerial parts, which may be either due to their individual or
additive eﬀect that speeds up the process most probably the
proliferation phase of wound healing (Figure 4).
5.Conclusion
In conclusion, the present study demonstrated that the
aerial parts of R. sanctus promote wound healing activity in
animal as a preclinical study. The methanolic extract showed
remarkable wound healing activity and it may be suggested
for treating various types’ wounds in animal and human
beings. Further studies with puriﬁed constituents compared
to the crude extracts might be needed to comprehend the
completemechanism of wound healing activity of R. sanctus.
12 day
Homestasis
Initial injury
Vasculer
response
Inﬂammation
Neutrophils
Macrophages
Lymphocytes
Proliferation
Repair and
formation of
new tissue
Fibroblasts
Collagen ﬁbers
Epithelialization
Remodeling
Collagen
crosslinking
Scar formation
Rubus sanctus
Figure 4: Hypothetical diagram of the wound healing mechanism
of methanolic extract of R. sanctus
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